Health Condition 1: null- psoriasis
Conditions
Interventions
Intervention1: Tab Propylthiouracil
: Trade Name: ptu
100mg Three times a day(every 8 hours) for 12 weeks
oral administration
Control Intervention1: nil: nil
Sponsors
SRM UIVERSITY
Science and Engineering Research Board Department of Science and Technology
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients with Psoriasis more than 20% of the body surface area 2.Patients who have not taken any other medication for one month prior to the study.
Exclusion criteria
Exclusion criteria: Psoriatic patients with the following criteria was excluded from the study • Pregnancy & lactation • Children below 18 yrs • Unstable psoriasis • Thyroid disorders • Other severe systemic illnesses.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Significant Decrease in Psoriasis Area and Severity Index score at 12 weeks of intervention Timepoint: 1 year 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Determination of mechanism of action and to assess duration of remission after intervention periodTimepoint: 1 year | — |
Countries
India
Contacts
Public ContactM Hemamalini Mphil
SRM Medical college Hospital and Research Centre, SRM University, Kattankulathur.
Outcome results
None listed